Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GL-0034 by Sun Pharmaceutical Industries for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Likelihood of Approval
GL-0034 is under clinical development by Sun Pharmaceutical Industries and currently in Phase II for Metabolic Dysfunction-Associated Steatotic Liver Disease...